Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7DF7

Crystal structure of human V-1 in the apo form

7DF7 の概要
エントリーDOI10.2210/pdb7df7/pdb
分子名称Myotrophin (2 entities in total)
機能のキーワードactin dynamics, ankyrin repeat protein, actin capping protein, cytosolic protein
由来する生物種Homo sapiens (Human)
タンパク質・核酸の鎖数2
化学式量合計26648.48
構造登録者
Takeda, S.,Nagae, T. (登録日: 2020-11-06, 公開日: 2021-01-20, 最終更新日: 2023-11-29)
主引用文献Takeda, S.,Koike, R.,Nagae, T.,Fujiwara, I.,Narita, A.,Maeda, Y.,Ota, M.
Crystal structure of human V-1 in the apo form.
Acta Crystallogr.,Sect.F, 77:13-21, 2021
Cited by
PubMed Abstract: V-1, also known as myotrophin, is a 13 kDa ankyrin-repeat protein that binds and inhibits the heterodimeric actin capping protein (CP), which is a key regulator of cytoskeletal actin dynamics. The crystal structure of V-1 in complex with CP revealed that V-1 recognizes CP via residues spanning several ankyrin repeats. Here, the crystal structure of human V-1 is reported in the absence of the specific ligand at 2.3 Å resolution. In the asymmetric unit, the crystal contains two V-1 monomers that exhibit nearly identical structures (C r.m.s.d. of 0.47 Å). The overall structures of the two apo V-1 chains are also highly similar to that of CP-bound V-1 (C r.m.s.d.s of <0.50 Å), indicating that CP does not induce a large conformational change in V-1. Detailed structural comparisons using the computational program All Atom Motion Tree revealed that CP binding can be accomplished by minor side-chain rearrangements of several residues. These findings are consistent with the known biological role of V-1, in which it globally inhibits CP in the cytoplasm.
PubMed: 33439151
DOI: 10.1107/S2053230X20016829
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.3 Å)
構造検証レポート
Validation report summary of 7df7
検証レポート(詳細版)ダウンロードをダウンロード

227111

件を2024-11-06に公開中

PDB statisticsPDBj update infoContact PDBjnumon